122 related articles for article (PubMed ID: 8742643)
1. Psychologic predictors of duodenal ulcer healing.
Levenstein S; Prantera C; Scribano ML; Varvo V; Berto E; Spinella S
J Clin Gastroenterol; 1996 Mar; 22(2):84-9. PubMed ID: 8742643
[TBL] [Abstract][Full Text] [Related]
2. Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing.
Reynolds JC
Ann Intern Med; 1989 Jul; 111(1):7-14. PubMed ID: 2567589
[TBL] [Abstract][Full Text] [Related]
3. Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Gisbert JP; Boixeda D; Martín De Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
Scand J Gastroenterol; 1997 Jul; 32(7):643-50. PubMed ID: 9246702
[TBL] [Abstract][Full Text] [Related]
4. Neurobiology of psychologic predictors of duodenal ulcer healing.
Friedman EH
J Clin Gastroenterol; 1996 Jul; 23(1):81. PubMed ID: 8835914
[No Abstract] [Full Text] [Related]
5. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
6. Ranitidine in the treatment of duodenal ulceration.
Peden NR; Boyd EJ; Saunders JH; Wormsley KG
Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
Reynolds JC; Schoen RE; Maislin G; Zangari GG
Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole and ranitidine in long-term treatment of duodenal ulcer: a double-blind comparison of length of time in remission.
Diaz de Rojas F; Berenguer J; Rodrigo L; Aran-Suau R; Da Silveira JC; Clerch L; Garcia Aparicio P; Caswell C
Dig Dis Sci; 1998 Sep; 43(9):1964-9. PubMed ID: 9753259
[TBL] [Abstract][Full Text] [Related]
9. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
11. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Schepp W; Classen M
Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
[TBL] [Abstract][Full Text] [Related]
12. Influence of stress on the healing and relapse of duodenal ulcers. A prospective, multicenter trial of 2109 patients with recurrent duodenal ulceration treated with ranitidine. RUDER Study Group.
Holtmann G; Armstrong D; Pöppel E; Bauerfeind A; Goebell H; Arnold R; Classen M; Witzel L; Fischer M; Heinisch M
Scand J Gastroenterol; 1992 Nov; 27(11):917-23. PubMed ID: 1455188
[TBL] [Abstract][Full Text] [Related]
13. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine.
Rohner HG; Gugler R
Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers.
Bank S; Greenberg RE; Magier D; Lavin PT
Clin Ther; 1991; 13(2):304-18. PubMed ID: 1863945
[TBL] [Abstract][Full Text] [Related]
15. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
16. Long-term symptom patterns in duodenal ulcer: psychosocial factors.
Levenstein S; Prantera C; Varvo V; Arca M; Scribano ML; Spinella S; Berto E
J Psychosom Res; 1996 Nov; 41(5):465-72. PubMed ID: 9032710
[TBL] [Abstract][Full Text] [Related]
17. Patterns of biologic and psychologic risk factors in duodenal ulcer patients.
Levenstein S; Prantera C; Varvo V; Scribano ML; Berto E; Spinella S; Lanari G
J Clin Gastroenterol; 1995 Sep; 21(2):110-7. PubMed ID: 8583075
[TBL] [Abstract][Full Text] [Related]
18. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
19. Sucralfate and ranitidine in the treatment of acute duodenal ulcer. Healing and relapse. Ulcer Study Group.
Koelz HR; Halter F
Am J Med; 1989 Jun; 86(6A):98-103. PubMed ID: 2660563
[TBL] [Abstract][Full Text] [Related]
20. Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients.
Lysy J; Karmeli F; Wengrower D; Rachmilewitz D
Scand J Gastroenterol; 1992; 27(1):13-9. PubMed ID: 1736336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
